ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test
- Posted on June 24, 2026
- By Bing News
- 0 Views
- 1 min read
ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test
By Sahil Pandey June 24 (Reuters) - ALZpath said on Wednesday it had signed a global licensing agreement with Abbott Laboratories to help advance blood-based testing for Alzheimer's disease, as companies race to offer easier-to-use diagnostic options for the brain-wasting disease. Here are some more details: • Abbott will incorporate ALZpath's antibody into a test designed to run on its Alinity
